Medicare Part D Prescription Claims for Brodalumab: Analysis of Annual Trends for 2017-2019.
Saved in:
| Title: | Medicare Part D Prescription Claims for Brodalumab: Analysis of Annual Trends for 2017-2019. |
|---|---|
| Authors: | Oulee A; Ms. Oulee, Ms. Javadi, and Ms. Ahn are from the Dermatology Research and Education Foundation, Irvine, California. Ms. Oulee also is from the University of California Riverside School of Medicine. Ms. Javadi also is from the David Geffen School of Medicine, University of California, Los Angeles. Ms. Ahn also is from the University of California San Diego School of Medicine, La Jolla. Dr. Maul is from the Department of Dermatology, University Hospital Zurich, Switzerland. Dr. Wu is from the Department of Dermatology, University of Miami Miller School of Medicine, Florida., Javadi SS; Ms. Oulee, Ms. Javadi, and Ms. Ahn are from the Dermatology Research and Education Foundation, Irvine, California. Ms. Oulee also is from the University of California Riverside School of Medicine. Ms. Javadi also is from the David Geffen School of Medicine, University of California, Los Angeles. Ms. Ahn also is from the University of California San Diego School of Medicine, La Jolla. Dr. Maul is from the Department of Dermatology, University Hospital Zurich, Switzerland. Dr. Wu is from the Department of Dermatology, University of Miami Miller School of Medicine, Florida., Ahn GS; Ms. Oulee, Ms. Javadi, and Ms. Ahn are from the Dermatology Research and Education Foundation, Irvine, California. Ms. Oulee also is from the University of California Riverside School of Medicine. Ms. Javadi also is from the David Geffen School of Medicine, University of California, Los Angeles. Ms. Ahn also is from the University of California San Diego School of Medicine, La Jolla. Dr. Maul is from the Department of Dermatology, University Hospital Zurich, Switzerland. Dr. Wu is from the Department of Dermatology, University of Miami Miller School of Medicine, Florida., Maul JT; Ms. Oulee, Ms. Javadi, and Ms. Ahn are from the Dermatology Research and Education Foundation, Irvine, California. Ms. Oulee also is from the University of California Riverside School of Medicine. Ms. Javadi also is from the David Geffen School of Medicine, University of California, Los Angeles. Ms. Ahn also is from the University of California San Diego School of Medicine, La Jolla. Dr. Maul is from the Department of Dermatology, University Hospital Zurich, Switzerland. Dr. Wu is from the Department of Dermatology, University of Miami Miller School of Medicine, Florida., Wu JJ; Ms. Oulee, Ms. Javadi, and Ms. Ahn are from the Dermatology Research and Education Foundation, Irvine, California. Ms. Oulee also is from the University of California Riverside School of Medicine. Ms. Javadi also is from the David Geffen School of Medicine, University of California, Los Angeles. Ms. Ahn also is from the University of California San Diego School of Medicine, La Jolla. Dr. Maul is from the Department of Dermatology, University Hospital Zurich, Switzerland. Dr. Wu is from the Department of Dermatology, University of Miami Miller School of Medicine, Florida. |
| Source: | Cutis [Cutis] 2022 Oct; Vol. 110 (4), pp. 212-214. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Frontline Medical Communications Country of Publication: United States NLM ID: 0006440 Publication Model: Print Cited Medium: Internet ISSN: 2326-6929 (Electronic) Linking ISSN: 00114162 NLM ISO Abbreviation: Cutis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
